151 related articles for article (PubMed ID: 22784520)
1. Effective treatment of chronic hand dermatitis with 36 continuous months of alitretinoin administration: report of three cases.
Gulliver WP; Baker KA
J Cutan Med Surg; 2012; 16(4):267-71. PubMed ID: 22784520
[TBL] [Abstract][Full Text] [Related]
2. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
Ruzicka T; Larsen FG; Galewicz D; Horváth A; Coenraads PJ; Thestrup-Pedersen K; Ortonne JP; Zouboulis CC; Harsch M; Brown TC; Zultak M
Arch Dermatol; 2004 Dec; 140(12):1453-9. PubMed ID: 15611422
[TBL] [Abstract][Full Text] [Related]
3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
4. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
5. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis.
Ham K; Maini P; Gooderham MJ
J Cutan Med Surg; 2014 Oct; 18(5):332-6. PubMed ID: 25186994
[TBL] [Abstract][Full Text] [Related]
6. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
7. Alitretinoin: a comprehensive review.
Cheng C; Michaels J; Scheinfeld N
Expert Opin Investig Drugs; 2008 Mar; 17(3):437-43. PubMed ID: 18321241
[TBL] [Abstract][Full Text] [Related]
8. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
9. DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema.
Ferrucci S; Persichini P; Gola M; Scandagli I; Pigatto P; Legori A; Musumeci ML; Micali G; D'Agata E; Schena D; Azzolini A; Gallo R; Trave I; Cristaudo A; Patruno C; Napolitano M; Zucca M; Piras V; Stingeni L; Bianchi L; Corazza M; Zedde P; Foti C; Romita P; Cannavò SP; Guarneri F
Dermatol Ther; 2021 May; 34(3):e14911. PubMed ID: 33619833
[TBL] [Abstract][Full Text] [Related]
10. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
Gola M; Milanesi N; D'Erme AM
G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
[TBL] [Abstract][Full Text] [Related]
14. Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis.
Tan J; Maari C; Nigen S; Bolduc C; Bissonnette R
J Dermatolog Treat; 2015; 26(4):373-5. PubMed ID: 25102893
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.
Halioua B; Paul C; Berbis P; Cambazard F; Doutre MS; Joly P; Richard MA; Aubin C; Gruber A; Chosidow O
Eur J Dermatol; 2019 Feb; 29(1):59-66. PubMed ID: 30827949
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands.
D'Erme AM; Milanesi N; Agnoletti AF; Maio V; Massi D; Gola M
Dermatol Ther; 2014; 27(1):21-3. PubMed ID: 24502306
[TBL] [Abstract][Full Text] [Related]
17. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.
Cheon DU; Kim JE; Ko JY; Ro YS
J Dermatol; 2019 Nov; 46(11):998-1005. PubMed ID: 31535403
[TBL] [Abstract][Full Text] [Related]
19. Oral alitretinoin in chronic refractory hand eczema: a "real life" case-series of 12 patients.
Kubica E; Ezzedine K; Lalanne N; Dartial Y; Taieb A; Milpied B
Eur J Dermatol; 2011; 21(3):454-6. PubMed ID: 21680291
[No Abstract] [Full Text] [Related]
20. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
